Drug Patents owned by Organon

1. Drug name - IMPLANON

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8888745 ORGANON Applicator for inserting an implant Aug, 2026

(3 years from now)

US10821277 ORGANON Kit for and method of assembling an applicator for inserting an implant May, 2027

(4 years from now)

US8722037 ORGANON X-ray visible drug delivery device Sep, 2027

(4 years from now)

US9757552 ORGANON Applicator for inserting an implant Jul, 2030

(7 years from now)

Drugs and Companies using ETONOGESTREL ingredient

Treatment: Prevention of pregnancy

Dosage: IMPLANT;IMPLANTATION

More Information on Dosage
Strength Dosage Availability
68MG/IMPLANT IMPLANT;IMPLANTATION Prescription

2. Drug name - ZETIA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7612058 ORGANON Methods for inhibiting sterol absorption Oct, 2025

(3 years from now)

US7612058

(Pediatric)

ORGANON Methods for inhibiting sterol absorption Apr, 2026

(3 years from now)

Drugs and Companies using EZETIMIBE ingredient

Treatment: To reduce elevated total-c, ldl-c, apo b and non-hdl-c in patients with primary hyperlipidemia by administration of ezetimibe alone or in combination with a statin or with fenofibrate; reduction of elevated plasma sterol and/or stanol levels in a mammal

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
10MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.